Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q4 and FY 2024 Financial Results
Go back to Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q4 and FY 2024 Financial Results| (NASDAQ: DNTH) | Delayed: 87.50 +5.01 (6.07%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $82.49 | 52 Week High | $ | |||
| Open | $85.16 | 52 Week Low | $ | |||
| Day High | $88.41 | P/E | N/A | |||
| Day Low | $83.91 | EPS | $ | |||
| Volume | 741,675 | |||||

